An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions

被引:225
作者
Larsen, MV
Lundegaard, C
Lamberth, K
Buus, S
Brunak, S
Lund, O
Nielsen, M
机构
[1] Tech Univ Denmark, Ctr Biol Sequence Anal, BioCentrum DTU, DK-2800 Lyngby, Denmark
[2] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, DK-2200 Copenhagen, Denmark
关键词
CTL epitope; MHC class I binding; proteasomal cleavage; TAP transport efficiency; artificial neural networks;
D O I
10.1002/eji.200425811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reverse immunogenetic approaches attempt to optimize the selection of candidate epitopes, and thus minimize the experimental effort needed to identify new epitopes. When predicting cytotoxic T cell epitopes, the main focus has been on the highly specific MHC class I binding event. Methods have also been developed for predicting the antigen-processing steps preceding MHC class I binding, including proteasomal cleavage and transporter associated with antigen processing (TAP) transport efficiency. Here, we use a dataset obtained from the SYFPEITHI database to show that a method integrating predictions of MHC class I binding affinity, TAP transport efficiency, and C-terminal proteasomal cleavage outperforms any of the individual methods. Using an independent evaluation dataset of HIV epitopes from the Los Alamos database, the validity of the integrated method is confirmed. The performance of the integrated method is found to be significantly higher than that of the two publicly available prediction methods BIMAS and SYFPEITHI. To identify 85% of the epitopes in the HIV dataset, 9% and 10% of all possible nonamers in the HIV proteins must be tested when using the BIMAS and SYFPEITHI methods, respectively, for the selection of candidate epitopes. This number is reduced to 7% when using the integrated method. In practical terms, this means that the experimental effort needed to identify an epitope in a hypothetical protein with 85% probability is reduced by 20-30% when using the integrated method. The method is available at http://www.cbs.dtu.dk/services/NetCTL. Supplementary material is available at http://www.cbs.dtu.dk/suppl/immunology/CTL.php.
引用
收藏
页码:2295 / 2303
页数:9
相关论文
共 27 条
  • [1] Sequence signals for generation of antigenic peptides by the proteasome: Implications for proteasomal cleavage mechanism
    Altuvia, Y
    Margalit, H
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2000, 295 (04) : 879 - 890
  • [2] [Anonymous], COMPLEX SYSTEMS MECH
  • [3] Brusic V, 1999, In Silico Biol, V1, P109
  • [4] Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach
    Buus, S
    Lauemoller, SL
    Worning, P
    Kesmir, C
    Frimurer, T
    Corbet, S
    Fomsgaard, A
    Hilden, J
    Holm, A
    Brunak, S
    [J]. TISSUE ANTIGENS, 2003, 62 (05): : 378 - 384
  • [5] Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide
    Craiu, A
    Akoplan, T
    Goldberg, A
    Rock, KL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10850 - 10855
  • [6] ENDERT VM, 1995, J EXP MED, V182, P1883
  • [7] Hakenberg Jorg, 2003, Appl Bioinformatics, V2, P155
  • [8] Prediction of proteasome cleavage motifs by neural networks
    Kesmir, C
    Nussbaum, AK
    Schild, H
    Detours, V
    Brunak, S
    [J]. PROTEIN ENGINEERING, 2002, 15 (04): : 287 - 296
  • [9] The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases
    Lévy, F
    Burri, L
    Morel, S
    Peitrequin, AL
    Lévy, N
    Bachi, A
    Hellman, U
    Van den Eynde, BJ
    Servis, C
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (08) : 4161 - 4171
  • [10] Definition of supertypes for HLA molecules using clustering of specificity matrices
    Lund, O
    Nielsen, M
    Kesmir, C
    Petersen, AG
    Lundegaard, C
    Worning, P
    Sylvester-Hvid, C
    Lamberth, K
    Roder, G
    Justesen, S
    Buus, S
    Brunak, S
    [J]. IMMUNOGENETICS, 2004, 55 (12) : 797 - 810